510(k) K791232
K791232 is an FDA 510(k) premarket notification submitted by Burroughs Wellcome Co. for the device "DAC-CEL T3". The FDA issued a decision of Substantially Equivalent on September 4, 1979. The device falls under product code CDP (Radioimmunoassay, Total Triiodothyronine), a Class II device regulated under 21 CFR 862.1710. Burroughs Wellcome Co. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- September 4, 1979
- Date Received
- July 2, 1979
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Radioimmunoassay, Total Triiodothyronine
- Device Class
- Class II
- Regulation Number
- 862.1710
- Review Panel
- CH
- Submission Type